Grant: Engage Grants Program
University of Guelph
$24,988.00
Characterization of Haemophilus parasuis
EF 2012-13
Résumé
The bacterium Haemophilus parasuis is the causative agent of an endemic disease of swine called GlÂsser's. A
commonly used way to control GlÂsser's disease is immunization with bacterial components that result in
protective immunity. Gallant Custom Laboratories, Inc. is the major producer of vaccines containing
farm-specific organisms for veterinary use in Canada. Serotyping is the main technique for typing and
differentiating H. parasuis strains, and is routinely used by Gallant Laboratories to select isolates for vaccine
production. Unfortunately, serotyping is not very discriminatory, and up to a third of isolates are non-typable
with this method. In addition, serotypes are only partially correlated with the ability of strains to cause disease.
To further complicate things, several strains of the same or of different serotypes may be present on a farm.
Thus, better means than serotyping are needed by Gallant Laboratories to characterize and select strains for the
production of vaccine with optimal efficacy.
The objective of this project is to develop two molecular methods to better characterize H. parasuis strains. The
first method called multilocus variable number of tandem repeat analysis (MLVA) is aimed at a better
differentiation of H. parasuis strains into multiple types. The second is aimed at assessing the ability of H.
parasuis strains to cause disease by using DNA amplification (PCR) to identify the virulence genes they carry.
The two methods will be developed using a set of reference H. parasuis strains. They will then be validated on
a variety of H. parasuis strains isolated from sick pigs and from healthy pigs that carry the organism in their
nose without developing any disease. Strains from sick pigs will be drawn from the extensive H. parasuis
collection from Gallant laboratories, while strains from healthy pigs in Ontario will be isolated in the course of
this study.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
431735-2012
Name nom
Boerlin, Patrick
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
24988
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Characterization of Haemophilus parasuis
Keyword
NSERC
Application summary
The bacterium Haemophilus parasuis is the causative agent of an endemic disease of swine called GlÂsser's. A
commonly used way to control GlÂsser's disease is immunization with bacterial components that result in
protective immunity. Gallant Custom Laboratories, Inc. is the major producer of vaccines containing
farm-specific organisms for veterinary use in Canada. Serotyping is the main technique for typing and
differentiating H. parasuis strains, and is routinely used by Gallant Laboratories to select isolates for vaccine
production. Unfortunately, serotyping is not very discriminatory, and up to a third of isolates are non-typable
with this method. In addition, serotypes are only partially correlated with the ability of strains to cause disease.
To further complicate things, several strains of the same or of different serotypes may be present on a farm.
Thus, better means than serotyping are needed by Gallant Laboratories to characterize and select strains for the
production of vaccine with optimal efficacy.
The objective of this project is to develop two molecular methods to better characterize H. parasuis strains. The
first method called multilocus variable number of tandem repeat analysis (MLVA) is aimed at a better
differentiation of H. parasuis strains into multiple types. The second is aimed at assessing the ability of H.
parasuis strains to cause disease by using DNA amplification (PCR) to identify the virulence genes they carry.
The two methods will be developed using a set of reference H. parasuis strains. They will then be validated on
a variety of H. parasuis strains isolated from sick pigs and from healthy pigs that carry the organism in their
nose without developing any disease. Strains from sick pigs will be drawn from the extensive H. parasuis
collection from Gallant laboratories, while strains from healthy pigs in Ontario will be isolated in the course of
this study.